Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Vivani MedicalSTU:U5P -6.40%35 EV-to-OCF is -4.74 as of Sep. 09, 2026. GuruFocus rates STU:U5P with a GF Score™ of 35/100. The stock has 1 warning sign investors should review. Among 1,404 Biotechnology companies, Vivani Medical ranks better than 55.7% on this metric.
EV-to-OCF is calculated as enterprise value divided by its cash flow from operations. As of today, Vivani Medical's Enterprise Value is €102.98 Mil.
Vivani Medical's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 was €-21.75 Mil. Therefore, Vivani Medical's EV-to-OCF for today is -4.74.
The historical rank and industry rank for Vivani Medical's EV-to-OCF or its related term are showing as below:
STU:U5P'
s EV-to-OCF Range Over the Past 10 Years
Min: -4.73 Med: 0 Max: -4.73
Current: -4.73
During the past 6 years, the highest EV-to-OCF of Vivani Medical was -4.73. The lowest was -4.73. And the median was .
STU:U5P's EV-to-OCF is ranked better than 55.7% of 1404
companies
in the Biotechnology industry
Industry Median: -3.65
vs STU:U5P: -4.73
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
EV-to-OCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Vivani Medical's PE Ratio (TTM) for today is calculated as:
Vivani Medical's share price for today is €1.17.
Vivani Medical's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.301.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Cash Flow from Operations is an important financial metric because it represents the cash generated from operating activities at a company's disposal. Companies with a low EV-to-OCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Vivani Medical EV-to-OCF Related Terms
Vivani Medical EV-to-OCF Historical Data
* Premium members only.
The historical data trend for Vivani Medical's EV-to-OCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Biotechnology subindustry, Vivani Medical's EV-to-OCF, along with its competitors' market caps and EV-to-OCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vivani Medical EV-to-OCF vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Vivani Medical's EV-to-OCF distribution charts can be found below:
* The bar in red indicates where Vivani Medical's EV-to-OCF falls into.
Vivani Medical's current Enterprise Value is €102.98 Mil.
Vivani Medical's Cash Flow from Operations for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was €-21.75 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vivani Medical (STU:U5P) has a EV-to-OCF of -4.74 as of Sep. 09, 2026. According to the industry distribution chart, Vivani Medical ranks #622 out of 1404 companies in the Biotechnology industry, placing it in the top 44.3%.
Is Vivani Medical's EV-to-OCF too high?
Vivani Medical's current EV-to-OCF is -4.74. Based on the distribution chart, Vivani Medical ranks #622 out of 1404 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Vivani Medical has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Vivani Medical's EV-to-OCF compare to BDTX and VTVT?
According to the Biotechnology industry distribution chart, Vivani Medical ranks #622 out of 1404 companies for EV-to-OCF. This puts Vivani Medical in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-OCF for a Biotechnology company?
A good EV-to-OCF depends on the Biotechnology industry context. However, EV-to-OCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-OCF mean?
A high EV-to-OCF can signal that a stock is expensive relative to its fundamentals. Vivani Medical's current EV-to-OCF is -4.74. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Vivani Medical stock overvalued right now?
Vivani Medical (STU:U5P) has a current EV-to-OCF of -4.74. The current EV-to-OCF is -4.74. Vivani Medical's overall GF Score™ is 35/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-OCF calculated?
EV-to-OCF is calculated from a company's financial statements. For Vivani Medical (STU:U5P), the current EV-to-OCF is -4.74 as of Sep. 09, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Vivani Medical Inc is a clinical stage biopharmaceutical company which develops miniature, ultra long-acting subdermal drug implant candidates utilizing its proprietary NanoPortal technology, which is designed to enable reversible, ultra long-acting, near constant-rate delivery of a broad range of medicines to treat chronic diseases. Vivani uses this platform technology to develop, and potentially commercialize, drug implant candidates, alone or in collaboration with pharmaceutical company partners, to address causes of poor clinical outcomes in the treatment of chronic diseases, including medication non-adherence, drug tolerability and administration challenges faced by certain patients. It operates in two segments the Biopharm Division and Neurostimulation Division.
35GF Score
Get the complete analysis for STU:U5P
EV-to-OCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
STU:U5P has been successfully added to your 
